Resistance to mitochondrial- and Fas-mediated apoptosis in human leukemic cells with acquired resistance to 9-β-D-arabinofuranosylguanosine

Biochemical and Biophysical Research Communications

Volumn 298, Issue 3, 2002, Pages 338-344

  Månsson, Emma ^a   Stridh, Helene ^b   Albertioni, Freidoun ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

9 D arabinofuranosylguanine; Apoptosis; Bcl xL; Cytochrome c; Fas; Resistance; Tributyltin

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CASPASE 3; CASPASE 9; CYTOCHROME C; DNA FRAGMENT; FAS ANTIGEN; GUANINE ARABINOSIDE; PROTEIN BCL XL; TRIBUTYLTIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL; LYMPHOBLAST; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; PERMEABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; WILD TYPE;

ANTIGENS, CD95; APOPTOSIS; ARABINONUCLEOSIDES; BASE SEQUENCE; CYTOCHROME C GROUP; DNA PRIMERS; DRUG RESISTANCE, NEOPLASM; HUMANS; LEUKEMIA; MITOCHONDRIA; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

ARA;

EID: 0036432268     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02471-3     Document Type: Article

References (33)

1. M.K. Bauer, M. Vogt, M. Los, J. Siegel, S. Wesselborg, K. Schulze-Osthoff, Role of reactive oxygen intermediates in activation-induced CD95 (APO- 1/Fas) ligand expression, J. Biol. Chem. 273 (1998) 8048-8055.
2. D.A. Carson, C.J. Carrera, D.B. Wasson, H. Yamanaka, Programmed cell death and adenine deoxynucleotide metabolism in human lymphocytes, Adv. Enzyme Regul. 27 (1988) 395-404.
3. J. Chandra, E. Mansson, V. Gogvadze, S.H. Kaufmann, F. Albertioni, S. Orrenius, Resistance of leukemic cells to 2-chlorodeoxyadenosine is due to a lack of calcium-dependent cytochrome c release, Blood 99 (2002) 655-663.
4. S. Curbo, C. Zhu, M. Johansson, J. Balzarini, A. Karlsson, Dual mechanisms of 9-β-D-arabinofuranosylguanine resistance in CEM T-lymphoblast leukemia cells, Biochem. Biophys. Res. Commun. 285 (2001) 40-45.
5. C. Friesen, I. Herr, P.H. Krammer, K.M. Debatin, Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells, Nat. Med. 2 (1996) 574-577.
6. V. Gandhi, W. Plunkett, C.O. Rodriguez Jr., B.J. Nowak, M. Du, M. Ayres, D.F. Kisor, B.S. Mitchell, J. Kurtzberg, M.J. Keating, Compound GW506U78 in refractory hematologic malignancies: Relationship between cellular pharmacokinetics and clinical response, J. Clin. Oncol. 16 (1998) 3607-3615.
7. D. Genini, I. Budihardjo, W. Plunkett, X. Wang, C.J. Carrera, H.B. Cottam, D.A. Carson, L.M. Leoni, Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway, J. Biol. Chem. 275 (2000) 29-34.
8. A. Gross, J. Jockel, M.C. Wei, S.J. Korsmeyer, Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction, and apoptosis, EMBO J. 17 (1998) 3878-3885.
9. P. Huang, L.E. Robertson, S. Wright, W. Plunkett, High molecular weight DNA fragmentation: A critical event in nucleoside analogue-induced apoptosis in leukemia cells, Clin. Cancer Res. 1 (1995) 1005-1013.
10. M. Jullig, S. Eriksson, Apoptosis induces efflux of the mitochondrial matrix enzyme deoxyguanosine kinase, J. Biol. Chem. 276 (2001) 24000-24004.
11. D.F. Kisor, W. Plunkett, J. Kurtzberg, B. Mitchell, J.P. Hodge, T. Ernst, M.J. Keating, V. Gandhi, Pharmacokinetics of nelarabine and 9-β-D-arabinofuranosyl guanine in pediatric and adult patients during a phase I study of nelarabine for the treatment of refractory hematologic malignancies, J. Clin. Oncol. 18 (2000) 995-1003.
12. L.M. Leoni, Q. Chao, H.B. Cottam, D. Genini, M. Rosenbach, C.J. Carrera, I. Budihardjo, X. Wang, D.A. Carson, Induction of an apoptotic program in cell-free extracts by 2-chloro-2′- deoxy-adenosine 5′-triphosphate and cytochrome c, Proc. Natl. Acad. Sci. USA 95 (1998) 9567-9571.
13. K. Lotfi, E. Mansson, C. Peterson, S. Eriksson, F. Albertioni, Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-β-D-arabinofuranosylguanine cytotoxicity, Biochem. Biophys. Res. Commun. 293 (2002) 1489-1496.
14. X. Luo, I. Budihardjo, H. Zou, C. Slaughter, X. Wang, Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors, Cell 94 (1998) 481-490.
15. I. Marzo, P. Perez-Galan, P. Giraldo, D. Rubio-Felix, A. Anel, J. Naval, Cladribine induces apoptosis in human leukaemia cells by caspase-dependent and -independent pathways acting on mitochondria, Biochem. J. 359 (2001) 537-546.
16. Y.Y. Mo, W.T. Beck, DNA damage signals induction of fas ligand in tumor cells, Mol. Pharmacol. 55 (1999) 216-222.
17. D.W. Nicholson, A. Ali, N.A. Thornberry, J.P. Vaillancourt, C.K. Ding, M. Gallant, Y. Gareau, P.R. Griffin, M. Labelle, Y.A. Lazebnik, et al., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis, Nature 376 (1995) 37-43.
18. I. Nicoletti, G. Migliorati, M.C. Pagliacci, F. Grignani, C. Riccardi, A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry, J. Immunol. Methods 139 (1991) 271-279.
19. Y. Nomura, O. Inanami, K. Takahashi, A. Matsuda, M. Kuwabara, 2-Chloro-2′-deoxyadenosine induces apoptosis through the Fas/Fas ligand pathway in human leukemia cell line MOLT-4, Leukemia 14 (2000) 299-306.
20. E.J. Reist, L. Goodman, Synthesis of 9-β-D-arabinofuranosylguanine, Biochemistry 3 (1964) 15-18.
21. C.O. Rodriguez Jr., J.K. Legha, E. Estey, M.J. Keating, V. Gandhi, Pharmacological and biochemical strategies to increase the accumulation of arabinofuranosylguanine triphosphatein primary human leukemia cells, Clin. Cancer Res. 3 (1997) 2107-2113.
22. C.O. Rodriguez Jr., V. Gandhi, Arabinosylguanine-induced apoptosis of T-lymphoblastic cells: Incorporation into DNA is a necessary step, Cancer Res. 59 (1999) 4937-4943.
23. C.O. Rodriguez Jr., B.S. Mitchell, M. Ayres, S. Eriksson, V. Gandhi, Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase, Cancer Res. 62 (2002) 3100-3105.
24. D.S. Shewach, B.S. Mitchell, Characterization of arabinosylguanine resistance in a lymphoblastoid cell line, Adv. Exp. Med. Biol. 195 (1986) 605-609.
25. A.H. Sjoberg, L. Wang, S. Eriksson, Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs, Mol. Pharmacol. 53 (1998) 270-273.
26. C.M. Stellrecht, C.O. Rodriguez Jr., V. Gandhi, Involvment of Fas ligand/receptor pathway in arabinosylguanine induced apoptosis in leukemic T-cells, Proc. Am. Assoc. Cancer Res. 43 (2002) 411.
27. H. Stridh, E. Fava, B. Single, P. Nicotera, S. Orrenius, M. Leist, Tributyltin-induced apoptosis requires glycolytic adenosine tris-phosphate production, Chem. Res. Toxicol. 12 (1999) 874-882.
28. H. Stridh, D. Gigliotti, S. Orrenius, I. Cotgreave, The role of calcium in pre- and postmitochondrial events in tributyltin-induced T-cell apoptosis, Biochem. Biophys. Res. Commun. 266 (1999) 460-465.
29. M.G. Vander Heiden, N.S. Chandel, E.K. Williamson, P.T. Schumacker, C.B. Thompson, Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria, Cell 91 (1997) 627-637.
30. A. Villunger, A. Egle, M. Kos, B.L. Hartmann, S. Geley, R. Kofler, R. Greil, Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells, Cancer Res. 57 (1997) 3331-3334.
31. L. Wang, A. Karlsson, E.S. Arner, S. Eriksson, Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine, J. Biol. Chem. 268 (1993) 22847-22852.
32. J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.I. Peng, D.P. Jones, X. Wang, Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked, Science 275 (1997) 1129-1132.
33. C. Zhu, M. Johansson, J. Permert, A. Karlsson, Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase, Biochem. Pharmacol. 56 (1998) 1035-1040.